Spyre Therapeutics (SYRE) Q2 2026 Earnings

7MayConfirmed
Q3 2025
Q4 2025
Q1 2026
Next
-0.76
-0.56
-0.35
-0.15

Details

Expected EPS
-0.665958
Actual EPS
N/A
Surprise EPS
0.67
Surprise Percent
+100%

Description

Spyre Therapeutics (SYRE) will report earnings of for Q2 2026 on May 07, 2026.

0 Comments

Share your thoughts